# pathway_0081

[All questions](../README.md) · [Summary](../SUMMARY.md) · [Method](../METHOD.md) · [Exact reviewer input](../inputs/pathway_0081.txt)

**Task:** `pathway`  
**Expected answer:** **A** — Antifungal biosynthesis. .

| Reviewer | Expected-answer support | Reasoning versus lookup |
|---|---|---|
| GPT-6 Luna | supported | reasoning-supported |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported |

The reviewers assess the question and its expected answer. Their agreement is not expert confirmation. An unusable review is an output failure, not a finding that the question is wrong.

## Complete original question

```text
[Protein Sequence]
MQAIISTAPGQAALVHDRPLPTIRDGYLLVKTKAVALNPTDWKHIEVTQKPGILFGCDYAGIVEQVGPGVQSGFQPGDRVAGFVHGGNSKEPQDGAFAEYIVAKADLQIHIPEHMSFEEAATLGVGITAVGQGLYQTLSLPFPSPSSIHEDGAEKPANPATQPILIYGASTASGVLGIQFAKLSGFAPLAVCSPDHFDLAERLGAVAVFDYADGEDAVEEIQDYVRGMGQPLLKAWDTISIPSSARFCGDALSSGNGPQYASLLSMTCPRPDVTSTTTMAYTVFGEDWGMGTAHFPASGVDAELGRRWWALVQQLLNEGRIQTHRIIAGEGGLDGVLGGLQQLRDSQVRGGKLVFRV

[Multiple Choices]
A. Antifungal biosynthesis. .
B. 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis. .
C. L-valine from pyruvate: step 3/4. .
D. One-carbon metabolism
```

<details>
<summary>Complete original system instructions</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## Reviewer assessments

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches the cited UniProt record, whose pathway annotation assigns it to antifungal biosynthesis with experimental evidence code ECO:0000269. The record links that annotation to a publication covering function and pathway; the paper itself was not independently reviewed here.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence is consistent with a trans-enoyl-reductase-type enzyme. Transferable knowledge associates such reductases with specialized metabolite assembly, making antifungal biosynthesis a better fit than tRNA modification, branched-chain amino-acid synthesis, or one-carbon metabolism among these choices. This is a probabilistic family-level inference, not proof of the antifungal product.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> A reductase-family inference can meaningfully separate the offered specialized-metabolite option from the three choices describing distinct primary or RNA-modification pathways, even though the precise pathway and product are not established by sequence alone.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The alternatives describe substantially different pathway types, and the enzyme-family inference favors A among those offered.


### Important caveats

- Reviewer-only annotations support the key but were not part of the original model input.
- The pathway assignment is linked to an experimental evidence code in UniProt; the underlying publication was not independently evaluated.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence is consistent with a trans-enoyl-reductase-type enzyme. Transferable knowledge associates such reductases with specialized metabolite assembly, making antifungal biosynthesis a better fit than tRNA modification, branched-chain amino-acid synthesis, or one-carbon metabolism among these choices. This is a probabilistic family-level inference, not proof of the antifungal product.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "A reductase-family inference can meaningfully separate the offered specialized-metabolite option from the three choices describing distinct primary or RNA-modification pathways, even though the precise pathway and product are not established by sequence alone."
  },
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The sequence matches the cited UniProt record, whose pathway annotation assigns it to antifungal biosynthesis with experimental evidence code ECO:0000269. The record links that annotation to a publication covering function and pathway; the paper itself was not independently reviewed here."
  },
  "important_caveats": [
    "Reviewer-only annotations support the key but were not part of the original model input.",
    "The pathway assignment is linked to an experimental evidence code in UniProt; the underlying publication was not independently evaluated."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The alternatives describe substantially different pathway types, and the enzyme-family inference favors A among those offered."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches the cited UniProt record, whose pathway annotation assigns it to antifungal biosynthesis with experimental evidence code ECO:0000269. The record links that annotation to a publication covering function and pathway; the paper itself was not independently reviewed here.",
    "evidence_ids": ["C5", "H3", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence is consistent with a trans-enoyl-reductase-type enzyme. Transferable knowledge associates such reductases with specialized metabolite assembly, making antifungal biosynthesis a better fit than tRNA modification, branched-chain amino-acid synthesis, or one-carbon metabolism among these choices. This is a probabilistic family-level inference, not proof of the antifungal product.",
    "missing_item_specific_fact": "",
    "reason": "A reductase-family inference can meaningfully separate the offered specialized-metabolite option from the three choices describing distinct primary or RNA-modification pathways, even though the precise pathway and product are not established by sequence alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The alternatives describe substantially different pathway types, and the enzyme-family inference favors A among those offered."
  },
  "important_caveats": [
    "Reviewer-only annotations support the key but were not part of the original model input.",
    "The pathway assignment is linked to an experimental evidence code in UniProt; the underlying publication was not independently evaluated."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The UniProt entry P0DXV9 explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence, PubMed:39105744). The protein is named 'Trans-enoyl reductase resD' and described as part of the 'Restricticin biosynthesis cluster' (restricticin being an antifungal compound). The sequence in the question matches the reviewed entry exactly (357 AA, SHA256 matched). The annotation is experimentally supported.

Citations as saved: [C5](#evidence-c5), [H3](#evidence-h3), [C4](#evidence-c4), [C6](#evidence-c6).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains recognizable enoyl reductase (ER) domain features: a Rossmann-like NAD(P)H-binding motif ('GASTASGVLGIQFAKLSGFAPLA' with GxxGxxG spacing) and the catalytic YXXXD motif ('YTVFGEDWGMGTAHFPASGVDA'). Enoyl reductase domains are characteristic of polyketide synthase (PKS) and fatty acid synthase (FAS) biosynthetic machinery. This domain architecture is fundamentally incompatible with: (B) tRNA modification enzymes (which use radical SAM, thiolation, or methyltransferase folds); (C) dihydroxy-acid dehydratase for valine biosynthesis (an Fe-S cluster enzyme with a completely different fold); (D) one-carbon metabolism enzymes (SHMT, MTHFR, formyltransferases — none have ER domains). In fungi, standalone ER domains (not embedded in large FAS/PKS multi-domain proteins) are predominantly found in secondary metabolite biosynthetic gene clusters, many of which produce antifungal or antimicrobial compounds. Among the four options, only 'Antifungal biosynthesis' (A) is compatible with an enoyl reductase domain in a fungal protein context.


**Missing item-specific fact**

Empty string, as saved.


**Reason**

> The enoyl reductase domain features in the sequence allow elimination of options B, C, and D through domain-incompatibility reasoning. The positive assignment to 'Antifungal biosynthesis' follows from the transferable knowledge that standalone ER domains in fungal proteins are typically embedded in specialized secondary metabolite clusters, a large fraction of which produce antifungal compounds. This is a family-level inference from ER domain biology and fungal natural product chemistry, not a lookup of this specific protein's annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The enoyl reductase domain is clearly incompatible with tRNA modification (B), amino acid biosynthesis (C), and one-carbon metabolism (D). Only option A is compatible with the observed domain architecture. No ambiguity among the offered choices.


### Important caveats

- The positive identification of 'antifungal' specifically (rather than, say, 'polyketide biosynthesis' or 'fatty acid biosynthesis') relies on the elimination of the other three options plus the probabilistic association of fungal standalone ER domains with secondary metabolite clusters. The sequence alone does not encode 'antifungal' as a specific property.
- The UniProt annotation is from a 2024 experimental study (PubMed:39105744) characterizing the restricticin biosynthetic cluster in Aspergillus sclerotiorum. The pathway label 'Antifungal biosynthesis' is a UniProt-curated descriptor for this specific natural product pathway.
- The reviewer-only evidence confirms the sequence matches P0DXV9 exactly, but the organism identity and specific compound name (restricticin) were not provided to the evaluated model.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains recognizable enoyl reductase (ER) domain features: a Rossmann-like NAD(P)H-binding motif ('GASTASGVLGIQFAKLSGFAPLA' with GxxGxxG spacing) and the catalytic YXXXD motif ('YTVFGEDWGMGTAHFPASGVDA'). Enoyl reductase domains are characteristic of polyketide synthase (PKS) and fatty acid synthase (FAS) biosynthetic machinery. This domain architecture is fundamentally incompatible with: (B) tRNA modification enzymes (which use radical SAM, thiolation, or methyltransferase folds); (C) dihydroxy-acid dehydratase for valine biosynthesis (an Fe-S cluster enzyme with a completely different fold); (D) one-carbon metabolism enzymes (SHMT, MTHFR, formyltransferases — none have ER domains). In fungi, standalone ER domains (not embedded in large FAS/PKS multi-domain proteins) are predominantly found in secondary metabolite biosynthetic gene clusters, many of which produce antifungal or antimicrobial compounds. Among the four options, only 'Antifungal biosynthesis' (A) is compatible with an enoyl reductase domain in a fungal protein context.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "",
    "reason": "The enoyl reductase domain features in the sequence allow elimination of options B, C, and D through domain-incompatibility reasoning. The positive assignment to 'Antifungal biosynthesis' follows from the transferable knowledge that standalone ER domains in fungal proteins are typically embedded in specialized secondary metabolite clusters, a large fraction of which produce antifungal compounds. This is a family-level inference from ER domain biology and fungal natural product chemistry, not a lookup of this specific protein's annotation."
  },
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H3",
      "C4",
      "C6"
    ],
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV9 explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence, PubMed:39105744). The protein is named 'Trans-enoyl reductase resD' and described as part of the 'Restricticin biosynthesis cluster' (restricticin being an antifungal compound). The sequence in the question matches the reviewed entry exactly (357 AA, SHA256 matched). The annotation is experimentally supported."
  },
  "important_caveats": [
    "The positive identification of 'antifungal' specifically (rather than, say, 'polyketide biosynthesis' or 'fatty acid biosynthesis') relies on the elimination of the other three options plus the probabilistic association of fungal standalone ER domains with secondary metabolite clusters. The sequence alone does not encode 'antifungal' as a specific property.",
    "The UniProt annotation is from a 2024 experimental study (PubMed:39105744) characterizing the restricticin biosynthetic cluster in Aspergillus sclerotiorum. The pathway label 'Antifungal biosynthesis' is a UniProt-curated descriptor for this specific natural product pathway.",
    "The reviewer-only evidence confirms the sequence matches P0DXV9 exactly, but the organism identity and specific compound name (restricticin) were not provided to the evaluated model."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The enoyl reductase domain is clearly incompatible with tRNA modification (B), amino acid biosynthesis (C), and one-carbon metabolism (D). Only option A is compatible with the observed domain architecture. No ambiguity among the offered choices."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0081",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The UniProt entry P0DXV9 explicitly annotates the pathway as 'Antifungal biosynthesis' with evidence code ECO:0000269 (experimental evidence, PubMed:39105744). The protein is named 'Trans-enoyl reductase resD' and described as part of the 'Restricticin biosynthesis cluster' (restricticin being an antifungal compound). The sequence in the question matches the reviewed entry exactly (357 AA, SHA256 matched). The annotation is experimentally supported.",
    "evidence_ids": ["C5", "H3", "C4", "C6"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains recognizable enoyl reductase (ER) domain features: a Rossmann-like NAD(P)H-binding motif ('GASTASGVLGIQFAKLSGFAPLA' with GxxGxxG spacing) and the catalytic YXXXD motif ('YTVFGEDWGMGTAHFPASGVDA'). Enoyl reductase domains are characteristic of polyketide synthase (PKS) and fatty acid synthase (FAS) biosynthetic machinery. This domain architecture is fundamentally incompatible with: (B) tRNA modification enzymes (which use radical SAM, thiolation, or methyltransferase folds); (C) dihydroxy-acid dehydratase for valine biosynthesis (an Fe-S cluster enzyme with a completely different fold); (D) one-carbon metabolism enzymes (SHMT, MTHFR, formyltransferases — none have ER domains). In fungi, standalone ER domains (not embedded in large FAS/PKS multi-domain proteins) are predominantly found in secondary metabolite biosynthetic gene clusters, many of which produce antifungal or antimicrobial compounds. Among the four options, only 'Antifungal biosynthesis' (A) is compatible with an enoyl reductase domain in a fungal protein context.",
    "missing_item_specific_fact": "",
    "reason": "The enoyl reductase domain features in the sequence allow elimination of options B, C, and D through domain-incompatibility reasoning. The positive assignment to 'Antifungal biosynthesis' follows from the transferable knowledge that standalone ER domains in fungal proteins are typically embedded in specialized secondary metabolite clusters, a large fraction of which produce antifungal compounds. This is a family-level inference from ER domain biology and fungal natural product chemistry, not a lookup of this specific protein's annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The enoyl reductase domain is clearly incompatible with tRNA modification (B), amino acid biosynthesis (C), and one-carbon metabolism (D). Only option A is compatible with the observed domain architecture. No ambiguity among the offered choices."
  },
  "important_caveats": [
    "The positive identification of 'antifungal' specifically (rather than, say, 'polyketide biosynthesis' or 'fatty acid biosynthesis') relies on the elimination of the other three options plus the probabilistic association of fungal standalone ER domains with secondary metabolite clusters. The sequence alone does not encode 'antifungal' as a specific property.",
    "The UniProt annotation is from a 2024 experimental study (PubMed:39105744) characterizing the restricticin biosynthetic cluster in Aspergillus sclerotiorum. The pathway label 'Antifungal biosynthesis' is a UniProt-curated descriptor for this specific natural product pathway.",
    "The reviewer-only evidence confirms the sequence matches P0DXV9 exactly, but the organism identity and specific compound name (restricticin) were not provided to the evaluated model."
  ]
}
```

</details>

## Complete reviewer-only evidence and qualifications

These source excerpts were available to the reviewers. They were not included in the original benchmark-solving input.

**Source applicability:**

```json
{
  "actual_author_source_snapshot": "unknown",
  "benchmark_sequence_length": 357,
  "benchmark_sequence_sha256": "9469ba1064baba46c4b8a0d5b1139bfae6c739cf6631aa8deeb889bb25b40b21",
  "current_entry_audit": {
    "entryVersion": 6,
    "firstPublicDate": "2025-02-05",
    "lastAnnotationUpdateDate": "2026-09-02",
    "lastSequenceUpdateDate": "2025-02-05",
    "sequenceVersion": 1
  },
  "current_record_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "current_sequence_comparison": "matched",
  "current_source_sequence_length": 357,
  "current_source_sequence_sha256": "9469ba1064baba46c4b8a0d5b1139bfae6c739cf6631aa8deeb889bb25b40b21",
  "current_status": "retrieved",
  "current_uniprot_release": "2026_03",
  "historical_cutoff_date": "2026-05-07",
  "historical_sequence_comparison": "matched",
  "historical_sequence_versions_checked": [
    {
      "entry_version": 4,
      "exact_sequence_comparison": "matched",
      "sequence_version": 1
    }
  ],
  "historical_status": "retrieved",
  "identity_origin": "reviewer-only accession inferred mechanically from original dataset image-path metadata; this accession/metadata was absent from evaluated model input",
  "latest_at_cutoff_sequence_comparison": "matched",
  "numbering": "Canonical entry coordinates; construct or isoform numbering is not assumed.",
  "requested_accession": "P0DXV9",
  "selected_historical_entry_version": 4,
  "selected_historical_record_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "selected_historical_source_sequence_length": 357,
  "selected_historical_source_sequence_sha256": "9469ba1064baba46c4b8a0d5b1139bfae6c739cf6631aa8deeb889bb25b40b21",
  "selected_historical_version": {
    "accession": "P0DXV9",
    "database": "Swiss-Prot",
    "entryVersion": 4,
    "firstRelease": "2026_01/2026_01",
    "firstReleaseDate": "28-Jan-2026",
    "lastRelease": "2026_01/2026_01",
    "lastReleaseDate": "28-Jan-2026",
    "name": "RESD_ASPSL",
    "sequenceVersion": 1
  }
}
```

**Qualifications:**

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C1",
  "excerpt": "\"P0DXV9\"",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/primaryAccession",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json"
}
```

### Evidence C2

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C2",
  "excerpt": "{\"entryVersion\":6,\"firstPublicDate\":\"2025-02-05\",\"lastAnnotationUpdateDate\":\"2026-09-02\",\"lastSequenceUpdateDate\":\"2025-02-05\",\"sequenceVersion\":1}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/entryAudit",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json"
}
```

### Evidence C3

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C3",
  "excerpt": "{\"lineage\":[\"Eukaryota\",\"Fungi\",\"Dikarya\",\"Ascomycota\",\"Pezizomycotina\",\"Eurotiomycetes\",\"Eurotiomycetidae\",\"Eurotiales\",\"Aspergillaceae\",\"Aspergillus\",\"Circumdati\"],\"scientificName\":\"Aspergillus sclerotiorum\",\"taxonId\":138282}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/organism",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json"
}
```

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C4",
  "excerpt": "{\"alternativeNames\":[{\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Restricticin biosynthesis cluster protein D\"}}],\"recommendedName\":{\"ecNumbers\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000305\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"1.-.-.-\"}],\"fullName\":{\"evidences\":[{\"evidenceCode\":\"ECO:0000303\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Trans-enoyl reductase resD\"}}}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/proteinDescription",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json"
}
```

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C5",
  "excerpt": "{\"commentType\":\"PATHWAY\",\"texts\":[{\"evidences\":[{\"evidenceCode\":\"ECO:0000269\",\"id\":\"39105744\",\"source\":\"PubMed\"}],\"value\":\"Antifungal biosynthesis\"}]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/comments/1",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json"
}
```

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/P0DXV9.json)

```json
{
  "evidence_id": "C6",
  "excerpt": "{\"citation\":{\"authors\":[\"Lu Y.\",\"Li Y.\",\"Dou M.\",\"Liu D.\",\"Lin W.\",\"Fan A.\"],\"citationCrossReferences\":[{\"database\":\"PubMed\",\"id\":\"39105744\"},{\"database\":\"DOI\",\"id\":\"10.1021/acs.jafc.4c04244\"}],\"citationType\":\"journal article\",\"firstPage\":\"18520\",\"id\":\"39105744\",\"journal\":\"J. Agric. Food Chem.\",\"lastPage\":\"18527\",\"publicationDate\":\"2024\",\"title\":\"Discovery of a hybrid molecule with phytotoxic activity by genome mining, heterologous expression, and OSMAC strategy.\",\"volume\":\"72\"},\"referenceNumber\":1,\"referencePositions\":[\"NUCLEOTIDE SEQUENCE [GENOMIC DNA]\",\"FUNCTION\",\"PATHWAY\"]}",
  "excerpt_format": "canonical JSON value at JSON pointer",
  "json_pointer": "/references/0",
  "retrieved_utc": "2026-11-02T04:29:49.517632+00:00",
  "sequence_comparison": "matched",
  "source": "UniProtKB current entry",
  "source_scope": "current snapshot; actual author source snapshot unknown",
  "source_sha256": "0ea3f01218a5d44f3983e214db9b5571f37b981454f4a8fcafcef626a639e914",
  "url": "https://rest.uniprot.org/uniprotkb/P0DXV9.json"
}
```

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4)

```json
{
  "entry_version": 4,
  "evidence_id": "H1",
  "excerpt": "ID   RESD_ASPSL              Reviewed;         357 AA.\nAC   P0DXV9;\nDT   05-FEB-2025, integrated into UniProtKB/Swiss-Prot.\nDT   05-FEB-2025, sequence version 1.\nDT   28-JAN-2026, entry version 4.\nDE   RecName: Full=Trans-enoyl reductase resD {ECO:0000303|PubMed:39105744};\nDE            EC=1.-.-.- {ECO:0000305|PubMed:39105744};\nDE   AltName: Full=Restricticin biosynthesis cluster protein D {ECO:0000303|PubMed:39105744};\nGN   Name=resD {ECO:0000303|PubMed:39105744};\nOS   Aspergillus sclerotiorum.\nOC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;\nOC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;\nOC   Aspergillus subgen. Circumdati.\nOX   NCBI_TaxID=138282;\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-02T04:29:51.221408+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 1-14",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "url": "https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4"
}
```

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4)

```json
{
  "entry_version": 4,
  "evidence_id": "H2",
  "excerpt": "RN   [1]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.\nRX   PubMed=39105744; DOI=10.1021/acs.jafc.4c04244;\nRA   Lu Y., Li Y., Dou M., Liu D., Lin W., Fan A.;\nRT   \"Discovery of a hybrid molecule with phytotoxic activity by genome mining,\nRT   heterologous expression, and OSMAC strategy.\";\nRL   J. Agric. Food Chem. 72:18520-18527(2024).\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-02T04:29:51.221408+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 15-21",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "url": "https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4"
}
```

### Evidence H3

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4)

```json
{
  "entry_version": 4,
  "evidence_id": "H3",
  "excerpt": "CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000269|PubMed:39105744}.\n",
  "excerpt_format": "literal contiguous UniProt flat-file lines",
  "retrieved_utc": "2026-11-02T04:29:51.221408+00:00",
  "sequence_comparison": "matched",
  "sequence_version": 1,
  "source": "UniSave archived UniProt entry",
  "source_locator": "lines 37-37",
  "source_scope": "record released no later than 2026-05-07; actual author source snapshot unknown",
  "source_sha256": "50948681abaa65d91ada1f1b7abe16915d33f113843973d2c3d87f65be73d5b0",
  "url": "https://rest.uniprot.org/unisave/P0DXV9?format=txt&versions=4"
}
```

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 81. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). [Source credits](../THIRD_PARTY_NOTICES.md).
